MENU
+Compare
HKMPF
Stock ticker: OTC
AS OF
Jul 24 closing price
Price
$27.96
Change
+$1.16 (+4.33%)
Capitalization
5.93B

HKMPF Hikma Pharmaceuticals plc. Forecast, Technical & Fundamental Analysis

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products... Show more

HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HKMPF with price predictions
Jul 25, 2025

Momentum Indicator for HKMPF turns positive, indicating new upward trend

HKMPF saw its Momentum Indicator move above the 0 level on July 24, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 55 similar instances where the indicator turned positive. In of the 55 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HKMPF's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 43 cases where HKMPF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

HKMPF moved above its 50-day moving average on July 24, 2025 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 117 cases where HKMPF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.737) is normal, around the industry mean (62.701). P/E Ratio (31.646) is within average values for comparable stocks, (88.783). HKMPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.021) settles around the average of (0.122) among similar stocks. P/S Ratio (2.365) is also within normal values, averaging (18.372).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HKMPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HKMPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

HKMPF paid dividends on May 01, 2025

Hikma Pharmaceuticals plc. HKMPF Stock Dividends
А dividend of $0.48 per share was paid with a record date of May 01, 2025, and an ex-dividend date of March 20, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1 New Burlington Place
Phone
+44 2073992760
Employees
8800
Web
https://www.hikma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MQQQ160.69N/A
N/A
Tradr 2X Long Innovation 100 Monthly ETF
EMLP37.80-0.10
-0.26%
First Trust North Amer Engy InfrasETF
IDEC30.33-0.10
-0.34%
Innovator Intl Dev Pwr Bffr ETF - Dec
BOIL37.18-0.19
-0.51%
ProShares Ultra Bloomberg Natural Gas
GOAU29.82-0.29
-0.96%
US Global GO GOLD and Prec Mtl Mnrs ETF

HKMPF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HKMPF has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HKMPF jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
EBS - HKMPF
34%
Loosely correlated
-4.02%
IRWD - HKMPF
22%
Poorly correlated
-0.40%
AMPH - HKMPF
22%
Poorly correlated
-1.15%
GRUSF - HKMPF
8%
Poorly correlated
N/A
HYPMY - HKMPF
7%
Poorly correlated
-4.52%
More